Neuraxis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuraxis and other ETFs, options, and stocks.About NRXS
NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear.
CEOBrian Carrico
CEOBrian Carrico
Employees21
Employees21
HeadquartersCarmel, Indiana
HeadquartersCarmel, Indiana
Founded2011
Founded2011
Employees21
Employees21
NRXS Key Statistics
Market cap29.16M
Market cap29.16M
Price-Earnings ratio-2.64
Price-Earnings ratio-2.64
Dividend yield—
Dividend yield—
Average volume38.87K
Average volume38.87K
High today$2.74
High today$2.74
Low today$2.61
Low today$2.61
Open price$2.66
Open price$2.66
Volume21.49K
Volume21.49K
52 Week high$6.20
52 Week high$6.20
52 Week low$1.33
52 Week low$1.33
Stock Snapshot
With a market cap of 29.16M, Neuraxis(NRXS) trades at $2.74. The stock has a price-to-earnings ratio of -2.64.
During the trading session on 2025-12-10, Neuraxis(NRXS) shares reached a daily high of $2.74 and a low of $2.61. At a current price of $2.74, the stock is +4.9% higher than the low and still 0.0% under the high.
Trading volume for Neuraxis(NRXS) stock has reached 21.49K, versus its average volume of 38.87K.
The stock's 52-week range extends from a low of $1.33 to a high of $6.20.
The stock's 52-week range extends from a low of $1.33 to a high of $6.20.
People also own
Based on the portfolios of people who own NRXS. This list is generated using Robinhood data, and it’s not a recommendation.